$CYCA
CYTTA CORP.

2022 Q3 Form 10-Q Financial Statement

#000147793222005929 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $3.280K $936.00 $936.00
YoY Change -86.4%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit $3.280K $936.00 $936.00
YoY Change -56.32%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $1.227M $1.163M $1.513M
YoY Change 29.77% 87.68% 178.18%
% of Gross Profit 37414.02% 124297.01% 161641.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.91K $11.90K $11.91K
YoY Change 0.0% 7.7% -33.5%
% of Gross Profit 363.11% 1271.69% 1272.44%
Operating Expenses $1.239M $1.175M $1.525M
YoY Change 31.03% 93.41% 175.34%
Operating Profit -$1.236M -$1.174M -$1.524M
YoY Change 31.73% 93.26% 175.18%
Interest Expense $220.00 $22.00 -$2.080K
YoY Change -101.04% -75.28% 511.76%
% of Operating Profit
Other Income/Expense, Net $22.00 $12.50K
YoY Change -99.82%
Pretax Income -$1.236M -$1.174M -$1.526M
YoY Change 28.8% 93.23% 175.38%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.236M -$1.174M -$1.526M
YoY Change 28.8% 93.23% 175.38%
Net Earnings / Revenue -37670.12% -125470.73% -163035.26%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.257K -$3.113K -$4.055K
COMMON SHARES
Basic Shares Outstanding 378.3M shares 377.1M shares 376.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $755.1K $1.569M $2.141M
YoY Change 335.98% 203.42% 314.08%
Cash & Equivalents $755.1K $1.569M $2.140M
Short-Term Investments
Other Short-Term Assets $32.90K $146.4K $411.7K
YoY Change -96.0% -86.24% -60.59%
Inventory $0.00 $0.00 $0.00
Prepaid Expenses $32.90K $146.4K
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $788.0K $1.716M $2.552M
YoY Change -28.52% 1.92% 55.08%
LONG-TERM ASSETS
Property, Plant & Equipment $123.0K $134.9K $146.8K
YoY Change -27.91% -23.36% -7.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $123.0K $134.9K $146.8K
YoY Change -27.91% -23.36% -7.9%
TOTAL ASSETS
Total Short-Term Assets $788.0K $1.716M $2.552M
Total Long-Term Assets $123.0K $134.9K $146.8K
Total Assets $911.0K $1.851M $2.699M
YoY Change -28.44% -0.47% 49.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $180.4K $140.1K $135.9K
YoY Change 291.74% 270.82% 4842.91%
Accrued Expenses
YoY Change
Deferred Revenue $780.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $449.2K $475.9K $278.2K
YoY Change 10.43% 414.28% -33.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $449.2K $475.9K $278.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $449.2K $475.9K $278.2K
YoY Change 10.42% 414.28% -33.36%
SHAREHOLDERS EQUITY
Retained Earnings -$27.88M -$26.64M -$25.47M
YoY Change 22.39%
Common Stock $379.8K $377.6K $376.8K
YoY Change 28.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $461.8K $1.375M $2.421M
YoY Change
Total Liabilities & Shareholders Equity $911.0K $1.851M $2.699M
YoY Change -28.44% -0.47% 49.52%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.236M -$1.174M -$1.526M
YoY Change 28.8% 93.23% 175.38%
Depreciation, Depletion And Amortization $11.91K $11.90K $11.91K
YoY Change 0.0% 7.7% -33.5%
Cash From Operating Activities -$814.2K -$571.1K -$473.9K
YoY Change 141.23% 93.91% -30.46%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -814.2K -571.1K -473.9K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -814.2K -571.1K -473.9K
YoY Change 136.67% -184335.48% 43.29%
FREE CASH FLOW
Cash From Operating Activities -$814.2K -$571.1K -$473.9K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$814.2K -$571.1K -$473.9K
YoY Change 145.96% 114.01% -26.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
cyca Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.01
CY2021Q2 us-gaap Interest Expense
InterestExpense
89 usd
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89146
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
900-7022
dei Security12g Title
Security12gTitle
Common Stock, $0.001 par value
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Central Index Key
EntityCentralIndexKey
0001383088
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
377565718 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
296236627 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
377565718 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
296237 usd
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
296236627 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-257458
dei Entity Registrant Name
EntityRegistrantName
CYTTA CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0505761
dei Entity Address Address Line1
EntityAddressAddressLine1
5450 W Sahara Ave Suite 300A
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
378315718 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1569367 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
140095 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
46054 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
780 usd
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3588 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
475859 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
406809 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23330613 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22774905 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
866245 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1273054 usd
CY2022Q2 us-gaap Revenues
Revenues
936 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
2809 usd
us-gaap Revenues
Revenues
70520 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
25277 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
936 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
2809 usd
us-gaap Gross Profit
GrossProfit
45243 usd
CY2022Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
216932 usd
CY2021Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
187991 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
895078 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
490952 usd
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
958388 usd
CY2021Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
419694 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2924096 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1188699 usd
us-gaap Operating Expenses
OperatingExpenses
3819174 usd
us-gaap Operating Expenses
OperatingExpenses
1679651 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-3816365 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-1634408 usd
CY2021Q2 cyca Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.00
cyca Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.01
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
22 usd
us-gaap Interest Expense
InterestExpense
48822 usd
us-gaap Interest Expense
InterestExpense
625 usd
us-gaap Net Income Loss
NetIncomeLoss
-3864522 usd
us-gaap Net Income Loss
NetIncomeLoss
-1634238 usd
CY2022Q2 cyca Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.00
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2021Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
665 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
795 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
89 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48157 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-170 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1174406 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-607774 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3864522 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1634238 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
377276830 shares
CY2021Q2 cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
294148907 shares
cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
351337053 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
866245 usd
CY2021Q4 cyca Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
859100 usd
CY2021Q4 cyca Series F Preferred Stock Issued For Cash Amount
SeriesFPreferredStockIssuedForCashAmount
2963500 usd
CY2021Q4 cyca Common Stock Issued For Accounts Payable Amount
CommonStockIssuedForAccountsPayableAmount
300000 usd
CY2021Q4 cyca Common Stock Issued For Conversion Of Series E Preferred Stock Amount
CommonStockIssuedForConversionOfSeriesEPreferredStockAmount
0 usd
CY2021Q4 cyca Common Stock Issued For Conversion Of Series E Preferred Share Amount
CommonStockIssuedForConversionOfSeriesEPreferredShareAmount
0 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1164106 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3824739 usd
CY2022Q1 cyca Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
122075 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1526010 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2420804 usd
CY2022Q2 cyca Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
128400 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1174406 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1374797 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
999905 usd
CY2020Q4 cyca Common Stock Issued For Stock To Be Issued Amount
CommonStockIssuedForStockToBeIssuedAmount
432000 usd
CY2020Q4 cyca Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
945000 usd
CY2020Q4 cyca Common Stock Cancelled Amount
CommonStockCancelledAmount
0 usd
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-472309 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1904596 usd
CY2021Q1 cyca Common Stock Issued For Cash Amount
CommonStockIssuedForCashAmount
25000 usd
CY2021Q1 cyca Capital Stock To Be Issued For Cash
CapitalStockToBeIssuedForCash
360000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-554156 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1735440 usd
CY2021Q2 cyca Series E Preferred Stock Issued For Cash Amount
SeriesEPreferredStockIssuedForCashAmount
322500 usd
CY2021Q2 cyca Common Stock Issued To Consultants Amount
CommonStockIssuedToConsultantsAmount
316750 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-607774 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1766917 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2963500 usd
us-gaap Profit Loss
ProfitLoss
-3864522 usd
us-gaap Profit Loss
ProfitLoss
-1634238 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1850850 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
707500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1396171 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-330416 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173196 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
28962 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
78765 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
776115 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35711 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
847646 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1569367 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
517230 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-47890 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
27694 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-20040 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20966 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-18998 usd
us-gaap Payments For Deposits
PaymentsForDeposits
50400 usd
us-gaap Payments For Deposits
PaymentsForDeposits
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
94040 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9433 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
129181 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
12394 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-2808 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
0 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-50480 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1567329 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-976002 usd
us-gaap Payments To Acquire Oil And Gas Equipment
PaymentsToAcquireOilAndGasEquipment
0 usd
us-gaap Payments To Acquire Oil And Gas Equipment
PaymentsToAcquireOilAndGasEquipment
61914 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61914 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2963500 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
682500 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
0 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
cyca Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
300000 usd
cyca Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
0 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26639427 usd
CY2021Q2 us-gaap Other Expenses
OtherExpenses
12501 usd
us-gaap Other Expenses
OtherExpenses
33336 usd
cyca Description Of Deferred Revenue
DescriptionOfDeferredRevenue
The subscription period is from August 2021 through July 2022
CY2022Q2 us-gaap Revenues
Revenues
936 usd
us-gaap Revenues
Revenues
2809 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.</p>
cyca Schedule Of Amortized The Value Of The Stock Issued
ScheduleOfAmortizedTheValueOfTheStockIssued
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance beginning of period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">772,394</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,443</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Value of common stock issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">894,841</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,261,750</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization of stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,499,874 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(776,115 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other prepaid expense activity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,966 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">18,998</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">146,395</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,064,076</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2 cyca Prepaid Expenses Beginning Balance
PrepaidExpensesBeginningBalance
772394 usd
CY2021Q2 cyca Prepaid Expenses Beginning Balance
PrepaidExpensesBeginningBalance
559443 usd
CY2022Q2 cyca Value Of Common Stock Issued
ValueOfCommonStockIssued
894841 usd
CY2021Q2 cyca Value Of Common Stock Issued
ValueOfCommonStockIssued
1261750 usd
CY2022Q2 cyca Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
-1499874 usd
CY2021Q2 cyca Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
-776115 usd
CY2022Q2 cyca Other Prepaid Expense Activity
OtherPrepaidExpenseActivity
-20966 usd
CY2021Q2 cyca Other Prepaid Expense Activity
OtherPrepaidExpenseActivity
18998 usd
CY2022Q2 cyca Prepaid Expenses Ending Balance
PrepaidExpensesEndingBalance
146395 usd
CY2021Q2 cyca Prepaid Expenses Ending Balance
PrepaidExpensesEndingBalance
1064076 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
0 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
78765 usd
CY2022Q2 us-gaap General And Administrative Costs In Inventory Amount Incurred
GeneralAndAdministrativeCostsInInventoryAmountIncurred
78765 usd
CY2022Q2 us-gaap Officers Compensation
OfficersCompensation
39063 usd
us-gaap Officers Compensation
OfficersCompensation
117189 usd
CY2021Q2 us-gaap Officers Compensation
OfficersCompensation
38992 usd
cyca Cash Flows Reportingpolicytextblock
CashFlowsReportingpolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Reporting segments</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p>
us-gaap Officers Compensation
OfficersCompensation
117118 usd
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
50000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230900 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230900 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
96006 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60295 usd
CY2022Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
134894 usd
CY2021Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
170605 usd
CY2022Q2 us-gaap Depreciation
Depreciation
11903 usd
CY2021Q2 us-gaap Depreciation
Depreciation
11052 usd
us-gaap Depreciation
Depreciation
35711 usd
us-gaap Depreciation
Depreciation
28962 usd
us-gaap Other Expenses
OtherExpenses
4163 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
216932 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
187991 usd
us-gaap Share Based Compensation
ShareBasedCompensation
895078 usd
us-gaap Share Based Compensation
ShareBasedCompensation
490952 usd
cyca Schedule Of Recorded Accounts Payable Related Parties
ScheduleOfRecordedAccountsPayableRelatedParties
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Management fees, Chief Executive Officer (CEO)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">30,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Bonus, CEO</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts payable, CTO</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,732</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">12,551</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">141,732</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">12,551</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
141732 usd
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
12551 usd
cyca Capital Stock
CapitalStock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 6 - CAPITAL STOCK </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Common Stock</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has authorized 500,000,000 common shares, par value $0.001. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. As of June 30, 2022, and September 30, 2021, there were 377,565,718 and 296,236,627, respectively, common shares issued and outstanding.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended June 30, 2022, the following shares of common stock were issued:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">13,650,000 shares of common stock issued for the conversion of 13,650,000 shares of Series E Preferred Stock.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">59,270,000 shares of common stock were issued for the conversion of 59,270,000 shares of Series F Preferred Stock.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">7,500,000 shares of common issued for services. The Company valued the shares at $1,109,575, based on the price of the common stock on the date the Company agreed to issue the shares.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">909,091 shares issued for payment of accounts payable. The amount of shares issued were based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Preferred Stock</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has 100,000,000 shares authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Series C Preferred Stock</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under the terms of the Certificate of Designation of Series C Preferred Stock, 12,000,000 shares of the Company’s preferred shares are designated as Series C Preferred Stock. Each share of Series C Preferred Stock is convertible into one hundred shares Common Stock and each share of Series C Preferred Stock is entitled to one hundred votes. As of June 30, 2022, and September 30, 2021, there were 600,000 shares of Series C Preferred Stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Series D Preferred Stock</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 30, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series D Preferred Stock, 50,000 shares of the Company’s preferred shares are designated as Series D Preferred Stock. Each share of Series D Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to two times the sum of all the number of shares of other classes of Corporation capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Corporation. On September 30, 2020, the Company issued 50,000 shares of Series D Preferred Stock to a Company controlled by the Company’s CEO, in satisfaction of $1,347,894 of capital stock to be issued. As of June 30, 2022, and September 30, 2021, there were 50,000 shares of Series D Preferred Stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Series E Preferred Stock</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 2, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 13,650,000 (as amended on June 10, 2021) were designated as Series E Preferred Stock. Each share of Series E Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series E Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. As of September 30, 2021, there were 13,650,000 shares of Series E Preferred Stock issued and outstanding. During the nine months ended June 30, 2022, the Company converted the 13,650,000 shares of Series E Preferred Stock to 13,650,000 shares of common stock. As of June 30, 2022, there were no shares of Series E Preferred stock issued and outstanding.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Series F Preferred Stock</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 24, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 59,270,000 were designated as Series F Preferred Stock. Each share of Series F Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock at any time by the holder. For so long as any shares of the Series F Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. The Series F Preferred Stock automatically converts to common stock after the shares of common stock closing market price is at least $0.20 for twenty (20) consecutive trading days. During the nine months ended June 30, 2022, the Company sold 59,270,000 shares of Series F Preferred Stock at $0.05 per share and received proceeds of $2,963,750. During the nine months ended June 30, 2022, the Company converted the 59,270,000 shares of Series F Preferred Stock to 59,270,000 shares of common stock. As of June 30, 2022, there were no shares of Series F Preferred Stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Stock Payable (Capital stock to be issued)</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2021, the Company had $323,583 of capital stock to be issued. During the nine months ended June 30, 2022, 4,000,000 shares of common stock was issued, which reduced the capital stock to be issued by $268,833. During the nine months ended June 30, 2022, the Company recorded 750,000 shares of common stock to be issued and recorded stock compensation expense of $105,075 ( the shares were issued in July 2022), As of June 30, 2022, the Company has $159,825 of capital stock to be issued, which is included in the liability section of the unaudited condensed balance sheet presented herein. </p>
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
377565718 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
296236627 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
7500000 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1109575 usd
cyca Common Stock Issued During Period Shares Account Payable
CommonStockIssuedDuringPeriodSharesAccountPayable
909091 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 cyca Common Stock Shares To Be Issued
CommonStockSharesToBeIssued
323583 usd
cyca Common Stock Issued
CommonStockIssued
4000000 shares
cyca Reduction In Capital Stcok To Be Issued
ReductionInCapitalStcokToBeIssued
268833 usd
CY2022Q2 cyca Common Stock To Be Issued
CommonStockToBeIssued
750000 shares
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
105075 usd
CY2022Q2 cyca Capital Stock To Be Issued
CapitalStockToBeIssued
159825 usd
CY2022Q2 cyca Subscription Agreement Deferred Revenues
SubscriptionAgreementDeferredRevenues
780 usd
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
3744 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173196 usd
CY2022Q2 cyca Vendor Deposits
VendorDeposits
0 usd
CY2021Q3 cyca Vendor Deposits
VendorDeposits
50400 usd
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
33427 usd
CY2021Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
21033 usd
CY2022Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
159825 usd
CY2021Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
323583 usd

Files In Submission

Name View Source Status
0001477932-22-005929-index-headers.html Edgar Link pending
0001477932-22-005929-index.html Edgar Link pending
0001477932-22-005929.txt Edgar Link pending
0001477932-22-005929-xbrl.zip Edgar Link pending
cyca-20220630.xsd Edgar Link pending
cyca_10q.htm Edgar Link pending
cyca_ex311.htm Edgar Link pending
cyca_ex312.htm Edgar Link pending
cyca_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
cyca-20220630_def.xml Edgar Link unprocessable
cyca-20220630_lab.xml Edgar Link unprocessable
cyca-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cyca_10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cyca-20220630_cal.xml Edgar Link unprocessable